Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
A Single Blind, (Subject and Investigator Blinded, Sponsor Unblinded), Two-Period, Placebo-Controlled, Randomized, Sequential, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS 7309 In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  5/16/2014
Worldwide Clinical Trials
mi
from
San Antonio, TX
Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
A Single Blind, (Subject and Investigator Blinded, Sponsor Unblinded), Two-Period, Placebo-Controlled, Randomized, Sequential, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS 7309 In Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 5/16/2014
Worldwide Clinical Trials
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pilot Study of Clinician-supported Patient Self-management of Hospital Insulin Therapy
Proof-of-concept Trial of Clinician-supported Patient Self-management of Hospital Insulin Therapy
Status: Enrolling
Updated:  5/19/2014
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Pilot Study of Clinician-supported Patient Self-management of Hospital Insulin Therapy
Proof-of-concept Trial of Clinician-supported Patient Self-management of Hospital Insulin Therapy
Status: Enrolling
Updated: 5/19/2014
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease (KXK005).
Status: Enrolling
Updated:  5/20/2014
University of Virginia Health System
mi
from
Charlottesville, VA
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease (KXK005).
Status: Enrolling
Updated: 5/20/2014
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels
Study of the Effect of Prebiotic Xylooligosaccharide (XOS) on Microbita and Blood Glucose
Status: Enrolling
Updated:  5/20/2014
UCLA Center for Human Nutrition
mi
from
Los Angeles, CA
Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels
Study of the Effect of Prebiotic Xylooligosaccharide (XOS) on Microbita and Blood Glucose
Status: Enrolling
Updated: 5/20/2014
UCLA Center for Human Nutrition
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Partners in Care With Semi-Structured Support Group
Status: Enrolling
Updated:  5/21/2014
Ke Ola Mamao
mi
from
Honolulu, HI
Partners in Care With Semi-Structured Support Group
Status: Enrolling
Updated: 5/21/2014
Ke Ola Mamao
mi
from
Honolulu, HI
Click here to add this to my saved trials
Partners in Care With Semi-Structured Support Group
Status: Enrolling
Updated:  5/21/2014
Kokua Kalihi Valley
mi
from
Honolulu, HI
Partners in Care With Semi-Structured Support Group
Status: Enrolling
Updated: 5/21/2014
Kokua Kalihi Valley
mi
from
Honolulu, HI
Click here to add this to my saved trials
Partners in Care With Semi-Structured Support Group
Status: Enrolling
Updated:  5/21/2014
Kula no na Po'e Hawaii
mi
from
Honolulu, HI
Partners in Care With Semi-Structured Support Group
Status: Enrolling
Updated: 5/21/2014
Kula no na Po'e Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I/II Study to Determine the Safety and Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax®) for the Treatment of Diabetic Foot Ulcer (DFU)
Status: Enrolling
Updated:  5/27/2014
VA New England Health Care Division
mi
from
Providence, RI
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I/II Study to Determine the Safety and Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax®) for the Treatment of Diabetic Foot Ulcer (DFU)
Status: Enrolling
Updated: 5/27/2014
VA New England Health Care Division
mi
from
Providence, RI
Click here to add this to my saved trials
An RCT Evaluation of a Diabetes Dashboard Team Model in Primary Care
Case Management for Underserved Hispanic Type 2 Diabetes Populations
Status: Enrolling
Updated:  6/4/2014
Baystate Medical Center
mi
from
Springfield, MA
An RCT Evaluation of a Diabetes Dashboard Team Model in Primary Care
Case Management for Underserved Hispanic Type 2 Diabetes Populations
Status: Enrolling
Updated: 6/4/2014
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
Status: Enrolling
Updated:  6/11/2014
Purdue University
mi
from
West Lafayette, IN
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
Status: Enrolling
Updated: 6/11/2014
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
UAMS Arkansas Children's Hospital
mi
from
Little Rock, AR
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
UAMS Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
University of Colorado Denver
mi
from
Aurora, CO
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Connecticut Children's Medical Center
mi
from
Hartford, CT
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Yale University
mi
from
New Haven, CT
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
University of Florida
mi
from
Gainesville, FL
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Emroy University
mi
from
Atlanta, GA
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Indiana University School of Medicine
mi
from
Indianapolis, IN
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
George Washington University Biostatistics Center
mi
from
Rockville, MD
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
George Washington University Biostatistics Center
mi
from
Rockville, MD
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Joslin Diabetes Center
mi
from
Boston, MA
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Massachusetts General Hospital
mi
from
Boston, MA
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Kansas City Children's Mercy Hospital
mi
from
Kansas City, MO
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Kansas City Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
St. Louis University
mi
from
St Louis, MO
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
St. Louis University
mi
from
St Louis, MO
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Washington University
mi
from
St Louis, MO
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Washington University
mi
from
St Louis, MO
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Columbia University
mi
from
New York, NY
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
State University of New York - Upstate Medical University
mi
from
Syracuse, NY
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
State University of New York - Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Case Western Reserve Univ
mi
from
Cleveland, OH
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
University of Oklahoma
mi
from
Oklahoma City, OK
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Baylor College of Medicine
mi
from
Houston, TX
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
Texas Tech Univ. Hlth Sci. Ctr.
mi
from
Lubbock, TX
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
Texas Tech Univ. Hlth Sci. Ctr.
mi
from
Lubbock, TX
Click here to add this to my saved trials
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated:  6/18/2014
University of Texas Health Science Center
mi
from
San Antonio, TX
TODAY Genetics Study
Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study
Status: Enrolling
Updated: 6/18/2014
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
The Children Hospital of Alabama
mi
from
Birmingham, AL
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
The Children Hospital of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Axis Clinical Trials
mi
from
Los Angeles, CA
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Local Institution
mi
from
Los Angeles, CA
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Local Institution
mi
from
Los Angeles, CA
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Nemours Children's Hospital
mi
from
Orlando, FL
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Nemours Children's Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Emroy University
mi
from
Atlanta, GA
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Kosair Charities Pediatric Clinical Research Unit
mi
from
Louisville, KY
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Kosair Charities Pediatric Clinical Research Unit
mi
from
Louisville, KY
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
LSUHSC Shreveport
mi
from
Shreveport, LA
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
LSUHSC Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Children's Mercy Hospital
mi
from
Kansas City, MO
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Women And Children'S Hopsital Of Buffalo
mi
from
Buffalo, NY
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Women And Children'S Hopsital Of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
ProMedica Toledo Children's Hospital
mi
from
Toledo, OH
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
ProMedica Toledo Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Mercy Children's Hospital
mi
from
Toledo, OH
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Mercy Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
Methodist Le Bonheur Hlthcare
mi
from
Memphis, TN
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
Methodist Le Bonheur Hlthcare
mi
from
Memphis, TN
Click here to add this to my saved trials
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/25/2014
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/25/2014
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials